Company profilePharmaceutical#673 of 1,318 in Pakistan✓ No DRAP alerts

KOHINOOR INDUSTRIES

Pharmaceutical company · 15 brands · 16 molecules

Ranked #7 of 8 companies in Antiseptics And Disinfectants

15 registered products 15 pharmaceutical brands 16 distinct molecules 0 DRAP alerts

Company overview

15
registered products
15
pharmaceutical brands
16
distinct molecules
3
therapeutic classes
0
DRAP alerts

KOHINOOR INDUSTRIES is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 15 product registrations across 16 distinct molecules. Its portfolio is concentrated in Antiseptics And Disinfectants and Drugs For Treatment Of Bone Diseases. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by KOHINOOR

7 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

7
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20257

Top molecules by brand count

Ibuprofen2 brands
Paracetamol2 brands
Omeprazole1 brand
Povidone-Iodine1 brand
Omeprazole.........................20Mg1 brand
Ibuprofen ...... 100 Mg1 brand
Ibuprofen ...... 200 Mg1 brand
Azithromycin....................250Mg1 brand
Paracetamol ...... 250 Mg1 brand

Therapeutic classes

Antiseptics And Disinfectants · 1Drugs For Treatment Of Bone Diseases · 1Antidiarrheals, Intestinal Antiinflammatory/Antiinfective · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official14 products · Rs 62.87 – Rs 767.53
Median across source: Rs 129.12

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 151 molecules not in this portfolio
AlbuterolAmikacinAminophyllineAmlodipineAmlodipine BaseAmmonium Chloride
MEDIATE PHARMACEUTICALS (PVT) LTD holds 109 molecules not in this portfolio
AcyclovirAlendronateAmlodipineAmoxicillinAmpicillinAmpicillin Base
SEMOS PHARMACEUTICALS (PVT) LTD. holds 54 molecules not in this portfolio
AmodiaquineAmodiaquine 150MgArtemetherArtesunateAscorbic AcidBisacodyl

Get the full profile for KOHINOOR

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.